Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/306% below fair value
$71.97−1.66 (-2.25%)
Close on Nov 13, 2026Market cap $229.14MP/E 21.5Yield –
Utah Medical Products r&d expenses
Research and development expenses are spending on new products and technology.
Utah Medical Products's R&D Expenses for the twelve months ending Sep 30, 2026 was $662.00K. For fiscal 2025 it was $668.00K, down 17.8% from the year before. Over ten years it grew 2.5% a year on average. The highest annual figure on record is $813.00K in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $668.00K | -17.8% |
| FY2024 | Dec 31, 2024 | $813.00K | +45.2% |
| FY2023 | Dec 31, 2023 | $560.00K | +13.6% |
| FY2022 | Dec 31, 2022 | $493.00K | -6.3% |
| FY2021 | Dec 31, 2021 | $526.00K | +8.2% |
| FY2020 | Dec 31, 2020 | $486.00K | +0.6% |
| FY2019 | Dec 31, 2019 | $483.00K | +6.4% |
| FY2018 | Dec 31, 2018 | $454.00K | +1.6% |
| FY2017 | Dec 31, 2017 | $447.00K | -5.9% |
| FY2016 | Dec 31, 2016 | $475.00K | -9.0% |
| FY2015 | Dec 31, 2015 | $522.00K | +13.5% |
| FY2014 | Dec 31, 2014 | $460.00K | -6.3% |
| FY2013 | Dec 31, 2013 | $491.00K | -12.8% |
| FY2012 | Dec 31, 2012 | $563.00K | – |
| FY2011 | Dec 31, 2011 | -$518.00K | -230.5% |
| FY2010 | Dec 31, 2010 | $397.00K | +10.0% |
| FY2009 | Dec 31, 2009 | $361.00K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $142.00K | -15.0% |
| Q2 FY2026 | Jun 30, 2026 | $154.00K | +14.1% |
| Q1 FY2026 | Mar 31, 2026 | $154.00K | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | $212.00K | +45.2% |
| Q3 FY2025 | Sep 30, 2025 | $167.00K | +21.0% |
| Q2 FY2025 | Jun 30, 2025 | $135.00K | +1.5% |
| Q1 FY2025 | Mar 31, 2025 | $154.00K | +6.9% |
| Q4 FY2023 | Dec 31, 2023 | $146.00K | +18.7% |
| Q3 FY2023 | Sep 30, 2023 | $138.00K | +23.2% |
| Q2 FY2023 | Jun 30, 2023 | $133.00K | -1.5% |
| Q1 FY2023 | Mar 31, 2023 | $144.00K | +17.1% |
| Q4 FY2022 | Dec 31, 2022 | $123.00K | -12.8% |
| Q3 FY2022 | Sep 30, 2022 | $112.00K | -11.8% |
| Q2 FY2022 | Jun 30, 2022 | $135.00K | +5.5% |
| Q1 FY2022 | Mar 31, 2022 | $123.00K | -5.4% |
| Q4 FY2021 | Dec 31, 2021 | $141.00K | +27.0% |
| Q3 FY2021 | Sep 30, 2021 | $127.00K | +1.6% |
| Q2 FY2021 | Jun 30, 2021 | $128.00K | +10.3% |
| Q1 FY2021 | Mar 31, 2021 | $130.00K | -3.7% |
| Q4 FY2020 | Dec 31, 2020 | $111.00K | -11.9% |
| Q3 FY2020 | Sep 30, 2020 | $125.00K | -3.8% |
| Q2 FY2020 | Jun 30, 2020 | $116.00K | +2.7% |
| Q1 FY2020 | Mar 31, 2020 | $135.00K | +17.4% |
| Q4 FY2019 | Dec 31, 2019 | $126.00K | +8.6% |
| Q3 FY2019 | Sep 30, 2019 | $130.00K | +20.4% |
| Q2 FY2019 | Jun 30, 2019 | $113.00K | -3.4% |
| Q1 FY2019 | Mar 31, 2019 | $115.00K | +1.8% |
| Q4 FY2018 | Dec 31, 2018 | $116.00K | +9.4% |
| Q3 FY2018 | Sep 30, 2018 | $108.00K | +4.9% |
| Q2 FY2018 | Jun 30, 2018 | $117.00K | -1.7% |
| Q1 FY2018 | Mar 31, 2018 | $113.00K | -4.2% |
| Q4 FY2017 | Dec 31, 2017 | $106.00K | -4.5% |
| Q3 FY2017 | Sep 30, 2017 | $103.00K | -23.7% |
| Q2 FY2017 | Jun 30, 2017 | $119.00K | 0.0% |
| Q1 FY2017 | Mar 31, 2017 | $118.00K | +7.3% |
| Q4 FY2016 | Dec 31, 2016 | $111.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $135.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $119.00K | – |
| Q1 FY2016 | Mar 31, 2016 | $110.00K | – |
See a number that looks wrong?